Product Information

BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.1016 per EA under NDC 24689078501. Its NADAC has been published 220 times since Mar 3, 2021.

FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 7.5 MG TABLET

Buspirone Hydrochloride
$0.1016per EA

Strength

7.5 mg/1

Manufacturer

Apnar Pharma LP

NDC

24689078501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209696

FDA Approved

5/3/2018

TE Code

AB

On Market Since

6/17/2024

Price Statistics

The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 220 times since Mar 3, 2021, and over the history we have for it it has declined 62.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1016 per EA
All-time high$0.2986 (May 12, 2021)
All-time low$0.0998 (Oct 21, 2026)
52-week high$0.1212
52-week low$0.0998
Median price$0.1623
Average price$0.1706
Largest weekly change-15.3% (Dec 22, 2021)
Weeks tracked220
Tracking sinceMar 3, 2021

Price History

1W

+1.8%

1M

+1.3%

3M

-2.9%

6M

-8.4%

1Y

-14.7%

3Y

-21.8%

5Y

-55.9%

All

-62.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Apnar Pharma LP, is $0.1016 per EA (NDC 24689078501), effective Nov 18, 2026.

How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 62.6%. It has been tracked across 220 weekly CMS publications since Mar 3, 2021.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?

Since Mar 3, 2021, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0998 (Oct 21, 2026) to a high of $0.2986 (May 12, 2021), with a median of $0.1623 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 7.5 MG TABLET?

BUSPIRONE HCL 7.5 MG TABLET (NDC 24689078501) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.